Allergan launches `Juvederm XC` in India

Updated: May 11, 2011, 00:00 AM IST

New Delhi: US-based Allergan Inc on Wednesday announced the launch of its anaesthetic dermal filler `Juvederm XC`, used to correct facial imperfections, in the country.

The Nasdaq-listed healthcare firm, which is present in the country through its Indian arm, plans to sell the product through leading aesthetic clinics across the country.

"The cost of the product will vary between Rs 15 thousand to Rs 70 thousand, depending upon the specific requirements of a customer," Allergan India Managing Director Raghu Kumar said.

The company, which will import the product from France, also plans to launch another variant of the Juvederm range of dermal fillers in the next 6-9 months, Kumar added.

Dermal fillers are materials/implants used to correct the imperfections of the face.

The company, which also makes Botox, got approval for the product from the US food and Drug Administration (USFDA) in January, 2010.

Juvederm XC contains local anaesthetic lidocaine to provide relief from pain during the treatment. Its key ingredient is hyaluronic acid that hydrates the skin and adds volume, contributing to the overall appearance of the skin.

The company, which believes in institutional sales as the drugs has to be administered by a professional cosmetologist, has tied up with well-known skin clinics such as Kaya and VLCC among others in the country.

The California-headquartered firm employs more than 9,000 people worldwide and posted net sales of USD 4.8 billion in FY10.